JPRN-UMIN000016475
Completed
未知
The late follow-up endoscopy as bleeding prevention after the gastric endoscopic submucosal dissection in the patient with thienopyridine derivative or low-dose aspirin and warfarin combination - ESD follow-up endoscopy Hokuriku Study
Japan Gastroenterological Endoscopy Society Hokuriku Chapter0 sites150 target enrollmentStarted: February 8, 2015Last updated:
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- Japan Gastroenterological Endoscopy Society Hokuriku Chapter
- Enrollment
- 150
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. there is a registration history in this study. 2\. including for other carcinomas, there is a history of radiation therapy to the upper abdomen. 3\. esophageal lesions, there is a plan of endoscopic therapy at the same time against duodenal lesions. 4\. within registration before the 28th there is the endoscopic treatment history with respect to the upper gastrointestinal tract lesions. 5\. within 28 days after treatment is scheduled to undergo an endoscopic examination or treatment with respect to the upper gastrointestinal tract. 6\. continuous systemic administration of antiplatelet or anticoagulant agents other than low\-dose aspirin and warfarin or thienopyridine, or steroids. 7\. temporary interruption of non\-steroidal anti\-inflammatory drugs is impossible from ESD treatment 7 days up to 28 days after ESD treatment. 8\. childbearing potential during pregnancy or lactating women. 9\. have a psychosis or mental symptoms. 10\. activity of bacterial and fungal infections. 11\. merged the poor control of hypertension. 12\. merged the respiratory disease requiring sustained oxygen administration. 13\. principal investigator or researcher has determined to be inappropriate.
Investigators
Similar Trials
Completed
Phase 3
Acute and delayed bleeding risk of endoscopic submucosal dissection for gastric neoplasia in patients with low-dose aspirin administration-multicenter randomized control studyGastric neoplasiaJPRN-UMIN000013177Multicenter randomized control study in patients with LDA during gastric ESD560
Recruiting
Not Applicable
The risk for bleeding complication after endoscopic biopsy in antithrombotic users.antithrombotics usersJPRN-UMIN000014369Department of Gastroenterology, Tohoku University Hospital3,000
Recruiting
Phase 1
Prevention of postoperative endoscopic disease recurrence in Crohn’s disease: a multicentric study that compares the systematic start of biological therapy immediately after an ileocolonic resection with the start of biological therapy in patients with endoscopic recurrence six months after ileocolonic resectioPatients with Crohn's disease undergoing surgery and having at least one risk factor for postoperative recurrence of the disease.MedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856Therapeutic area: Diseases [C] - Digestive System Diseases [C06]CTIS2022-500311-39-00Z Leuven352
Completed
Not Applicable
Phase II study on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by placement of 4Fr prophylactic pancreatic duct stent in patients who is performed endoscopic pancreatic duct injection (multicenter study)JPRN-UMIN000031972Wakayama Medical University250
Not yet recruiting
Not Applicable
Endoscopic clip application and endoscopic hemost asis powderDiseases of the digestive systemKCT0008471Asan Medical Center630